Bionano Genomics Is Maintained at Buy by BTIG
Bionano Genomics Is Maintained at Buy by BTIG
Express News | BTIG Maintains Buy on Bionano Genomics, Lowers Price Target to $2
Bionano Genomics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 82.65% BTIG $3 → $2 Maintains Buy 03/07/2024 447.95% Scotiabank $7 → $6 Maintains Sector Outper
Strong Performance and Strategic Initiatives Underpin Buy Rating for BioNano Genomics
Bionano Stock Climbs 7% in Wake of Q1 Report, Software Upgrades
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2024 Earnings Call Transcript
BioNano Genomics (BNGO) Gets a Buy From Scotiabank
Q1 2024 Bionano Genomics Inc Earnings Call
Bionano Genomics Inc (BNGO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
Bionano Announces Series of Major Advancements to Its Suite of Computational Tools for Comprehensive Cancer Analysis
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced significant upgrades to its suite of computational tools for comprehensive cancer analysis. These ad
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript
Bionano Reaffirms FY24 Revenue Guidance $37M-$41M
Bionano Reaffirms FY24 Revenue Guidance $37M-$41M
Bionano Genomics up 7% on Narrowed Quarterly Loss, Revenue Beat
Bionano Genomics Q1 2024 GAAP EPS $(0.60) Beats $(0.65) Estimate, Sales $8.769M Beat $8.492M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.
Express News | Bionano Genomics Inc: Expects Reduction Will Be Substantially Completed by June 30
Express News | Bionano Genomics Inc: Determined Reduction Expected to Result in Total Restructuring Charges of About $4.6 Mln
Express News | Bionano Genomics Inc: On March 5, Co Filed Report Disclosing Corporate Reorganization Plan
10-Q: Quarterly report
Bionano Genomics 1Q Rev $8.8M >BNGO
Bionano Genomics 1Q Rev $8.8M >BNGO